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SUMMARY  13 
Introduction:  Retention in care and re-engagement of loss to follow-up (LTFU) patients is a 14 
priority challenge in pediatric HIV care. We aimed to assess whether a telephone-call active 15 
tracing program facilitated re-engagement in care (RIC) in the Manhiça District Hospital, 16 
Mozambique. 17 
Methods Telephone tracing of LTFU children was performed from July 2016 to March 18 
2017.  Both ART (antiretroviral treatment) and preART patients were included in this study. 19 
LTFU was defined as not attending the clinic for ≥120 days after last attended visit. 20 
Reengagement was determined 3-months after attempt to contact.  21 
Results: total of 144 children initially identified as LTFU entered the active tracing program 22 
and 37 were reached by means of telephone tracing. RIC was 57% (95% CI, 39–72%) among 23 
children who could be reached versus 18% (95% CI, 11–26%) of those who could not be 24 
reached (p=0.001). 25 
Conclusion: Telephone tracing could be an effective tool for facilitating reengagement in 26 
pediatric HIV care. However, the difficulty of reaching patients is an obstacle that can 27 













     Each step in the pediatric HIV care cascade presents challenges, leading to high rates of loss 39 
to follow-up (LTFU) and early mortality that exceed those reported in adults(1–3).  40 
Retention in care and treatment is necessary to achieve and maintain viral suppression (4). 41 
Continuous care allows detection of medication toxicity, treatment failure and the need for 42 
dosage/drug modifications, and provides social support (5–8). In Mozambique, one of the 43 
countries most affected by the epidemic, the  12-month retention rate among children under  44 
the age of 15 newly initiating antiretroviral treatment (ART) is around 70%(9). 45 
 SMS-text reminders for caregivers of HIV-infected children have been effective in increasing 46 
medical appointment attendance in Cameroon (10). However, little data explains the effects 47 
of phone calls on re-engagement in care (RIC) of pediatric HIV patients who were LTFU. 48 
      We aimed to assess whether a phone-call based active tracing program facilitated RIC of 49 
both ART and preART HIV children who were LTFU in the Manhiça District Hospital (MDH) in 50 
Southern Mozambique. 51 
 52 
Materials and methods 53 
Study setting 54 
      The study was conducted at the Centro de Investigação em Saúde de Manhiça (CISM), a 55 
semi-rural area in Southern Mozambique with a high HIV burden of disease(11). The CISM 56 
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collaborates closely with the Manhiça District Hospital (MDH), a public hospital offering free 57 
HIV services.  HIV-infected children are followed-up in a pediatric clinic and seen every 3 58 
months until the age of 15, when they are referred to the adult clinic. At the time of the study, 59 
for children over 5 years of age, ART eligibility was defined as CD4 count below 500 cell/mm3 60 
or HIV WHO stage III or IV; the first line of treatment was azidothymidine(AZT) + lamivudine 61 
(3TC) + nevirapine (NVP)/efavirenz (EFV). Universal treatment was recommended for all HIV-62 
infected children under 5 and first line was AZT+3TC+NVP/ lopinavir (LPVr)(12). 63 
Study design and procedures 64 
      This is a programmatic evaluation of the first 9 months (July 2016 to March 2017) of an 65 
Active Tracing Program (ATP) implemented at the MDH. This analysis was nested in a larger 66 
prospective pediatric cohort of HIV positive children < 15 years in care at the MDH. Data from 67 
clinic visits are routinely collected and entered into the MDH HIV pediatric cohort database 68 
(MDHIVPed). 69 
The evaluation included all HIV-positive children < 15 years among whom HIV care was 70 
initiated at the MDH between February 2013 and March 2017.  Both preART and ART patients 71 
were included in this study. Children were included in the ATP if considered LTFU at any time 72 
between July 2016 and March 2017. Children LTFU were identified monthly from the 73 
MDHIVPed and caregivers were contacted by telephone using the contact information that 74 
was registered in the patient chart on enrollment in HIV care. If the caregiver or child was 75 
reached by the ATP, the counselor provided a telephone counseling session, inquired about 76 
the reason for missed appointment and rescheduled the appointment. If the child returned to 77 
the clinic, an ATP counselor and a clinician from the MDH conducted the clinic visit. All the ATP 78 
information was collected in a specific questionnaire in electronic format in Open Data Kit 79 
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software 1.4 (ODK) (13)during the visit and uploaded into a database in REDCap (Research 80 
Electronic Data Capture) Software 5.7.3 (14). For the patients included in this study, phone 81 
based tracing in the context of this study was the only intervention to promote or incentivize 82 
retention applied. 83 
Study definitions 84 
LTFU was defined as not having attended the clinic for ≥120 days following last visit among 85 
patients considered alive and not transferred to another unit. Time of LTFU was calculated as 86 
the number of days from last clinic visit until ATP enrollment. 87 
Patients reached by the ATP were defined as those whose caregiver received a phone call and 88 
communicated with the ATP counselor.   89 
Patients with successful RIC were defined as HIV positive children who were LTFU and  90 
returned for a clinic visit within 3 months after being enrolled in the ATP.  91 
Statistical considerations 92 
     Data were analyzed using Stata statistical software version 14.2 (Stata Corp., College 93 
Station, Texas, USA). We performed descriptive analysis of clinical and socio-demographic 94 
variables on entry into the ATP. Medians and interquartile ranges (IQR) were calculated to 95 
describe continuous variables, and categorical variables were expressed using frequencies. 96 
Differences between patients who could be reached and who could not be reached by 97 
telephone tracing were assessed using χ2 and Fisher’s exact test for categorical variables and 98 
Wilcoxon test for continuous variables. Patients not reached by means of telephone tracing 99 
included patients with absent telephone numbers in charts and those who could not be 100 
reached by the ATP counselor.  101 
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The proportion of patients who were re-engaged in care was the quotient of children re-102 
engaged in care and those LTFU.       103 
We performed univariate and multivariable analyses to determine the associations between 104 
clinical and socio-demographic patient characteristics and the primary outcome of RIC.  105 
Unadjusted and adjusted odds ratios were estimated. All associations with a p-value <0.2 in 106 
the univariate analysis were included in a multivariate logistic regression model, which was 107 
adjusted for sex and age at time of the enrollment. Variables with a p-value of <0.2 but with > 108 
30% missing data were excluded from the final multivariate regression model.  109 
Ethics statement 110 
     Children and caregivers in the prospective MDH HIV pediatric cohort signed an informed 111 
consent approved by the Mozambican National Bioethics Committee and the Barcelona 112 
Hospital Clinic Institutional Review Board. The specific active tracing activities were developed 113 
under the national recommendations and the district health services. 114 
Results 115 
Study profile and population characteristics 116 
Care was initiated in a total of 422 children [average age, 4.9 (4.2 SD) years] at the MDH 117 
between February 2013 and March 2017. Of those, 269 children were flagged as potential 118 
LTFU between July 2016 and March 2017 in the MDHIVPed. Of these, 125 (46%) were 119 
identified as non-LTFU after reviewing the medical charts and were excluded from the ATP 120 
(Figure 1). Most exclusions were because of health facility transfer (N=56; 45%) or death 121 
(N=12; 9%). A total of 144 children met the inclusion criteria [median age at ATP enrollment, 122 
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8.37 years (IQR: 3.74–11.33); number of male children, 59%]. However, in 54 (37%) patients, 123 
telephone tracing was not attempted because no telephone number was registered in the 124 
chart (Figure 1). Telephone tracing was attempted for 90 children, and was unsuccessful for 125 
53 (58%), primarily due to invalid telephone numbers.  126 
     Of 37 children successfully reached, 3 were reported as deaths, 2 had self- transferred to 127 
another health clinic and 2 had missed an appointment without fulfilling LTFU definition. 128 
(Figure 1). When assessing the main reasons for children discontinuing HIV care, caregivers 129 
reported forgetting about appointments (50%), moving residence (23%) and ill caregiver (7%), 130 
among others. The baseline descriptive characteristics of children who could be reached and 131 
those who could not be reached by means of telephone tracing were comparable (Table 1). 132 
Intervention effect and factors associated with reengagement in care 133 
RIC occurred in 21 of 37 [57% (95% CI 39%-72%)] of children LTFU reached through the ATP 134 
and in 19 of 107 [18% (95% CI 11%-26%)] of those not reached by the ATP. Table 2 shows the 135 
results of the univariate and multivariate analysis evaluating the association of variables with 136 
RIC for those patients LTFU included in the tracing program. Increased age at ATP enrollment, 137 
lower CD4 at enrollment in care, orphaned, reached by telephone tracing, fewer months of 138 
LTFU and more months in care were significantly associated with RIC in the univariate analysis.  139 
In the multivariate model, the following three variables showed a statistically significant 140 
association with RIC; age at ATP enrollment [adjusted odds ratio (AOR) 1.11, 95% CI 1.01 - 141 
1.24; p-value 0.036], time LTFU (in months) (AOR 0.76, 95% CI 0.60 - 0.96; p-value 0.021) and 142 
children who were reached by telephone tracing (AOR 7.20, 95% CI 2.27 – 22.78; p-value 143 
0.001) (Table 2).  144 
Discussion  145 
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The results of this study show that among HIV-infected children enrolled in care at the MDH, 146 
the telephone numbers of a high number, 107 (74%), in the chart were not working, reducing 147 
the potential impact of ATP. Importantly, in 54 of 107 cases (50.5%), telephone tracing was 148 
not attempted due to missing telephone number and in 44 (41.1%) cases, the registered 149 
number was invalid. Other studies in sub-Saharan Africa have shown logistical problems in 150 
telephone tracing programs in adults HIV patients owing to incomplete, outdated or 151 
erroneous telephone numbers on patients’ files or lost/disconnected cell phone numbers (15).  152 
This may be an even greater problem for tracing children dependent on a caregiver, as 153 
disconnected mobile phone service may indicate patient deaths(15) or in our case, caregiver 154 
death or change in caregiver. Results of home tracing studies  in HIV-infected patients vary in 155 
terms of patients reached (16–18). While a study in Malawi could reach 73% of all HIV LTFU 156 
patients of all ages(16), a South African study could reach only 31% adults with tuberculosis 157 
or HIV lost to care (17). However several studies combining telephone and home tracing could 158 
reach 85% of LTFU adults patients with HIV or tuberculosis (18) and 79% of HIV LTFU 159 
children(19), respectively.  Therefore, multi-method tracing approach could improve the 160 
effectiveness to reengage HIV LTFU children, although further studies would be needed to 161 
evaluate the cost-benefit and long-term sustainability. 162 
Telephone tracing was associated with reengagement among HIV-infected children LTFU. A 163 
total of 57% (95% CI 39%-72%) of cases that could be reached by the ATP reengaged in care 164 
and had 7-fold greater odds of RIC than those who could not be reached.  Similar percentages 165 
were found in a home tracing program in South Africa (61%)(17)  and a combined telephone-166 
home tracing in Kenya (59%) (18), and slightly higher percentages were described Malawi 167 
(74%) (16). However, these studies included  adults(16–18) and patients with tuberculosis lost 168 
to care (17,18). 169 
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Our study is one of the few addressing the predictors and/or risk factors of RIC following ATP 170 
among children LTFU.  We have shown that in addition to ATP, time spent LTFU was associated 171 
with RIC. For each additional month of LTFU, the likelihood of RIC decreased (AOR 0.76, 95% 172 
CI 0.60 - 0.96; p-value 0.021). This inverse relationship between time spent LTFU and 173 
probability of RIC highlights the importance of early tracing programs soon after 174 
abandonment of care. Older children had higher probabilities of RIC in our study (AOR 1.11, 175 
95% CI 1.01-1.24; p-value 0.036). Taking into account these findings as well as those 176 
from several studies (20–22) that indicate that younger children have a higher risk of LTFU and 177 
death, retention efforts should be increased in young children.  178 
Although gender was not concluded as an indicator of RIC in our study, a study published in 179 
2010 in Malawi, including patients of all ages, found women more likely to be RIC after 180 
LTFU(16). In our study, 71 % of caregivers reached were female thus not allowing conclusion. 181 
However, the caregiver gender might be important since the ultimately, they are the decision-182 
makers regarding the child’s healthcare. Several studies(16,23) have reported that patients in 183 
whom ART was initiated were more likely to return to the clinic than those in whom ART was 184 
never initiated. A possible explanation is that these patients likely have a greater 185 
understanding of the importance of ART compared with those who have never been on 186 
treatment. In this study, only 15% of participants were not on ART, limiting our ability to 187 
explore this association.  We have also taken into account the idea that the proportion of 188 
patients defaulting in clinic may somehow differ to those defaulting in ART.  In this study, we 189 
were not able to differentiate between the two, as we included all patients in whom care  was 190 
initiated defaulting in clinic, regardless of ART use.  191 
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Residence-clinic distance has been documented as a barrier to follow-up in many African 192 
settings among HIV-positive individuals, pediatric and adult alike(24), but we did not see 193 
associations with RIC. Determinants of LTFU and RIC could in fact be different. Other 194 
important variables such as patient/caregiver work schedules’ interference with long wait 195 
times for appointments, as well as the presence of social support, could impact RIC. 196 
Qualitative studies have shown structural and social factors also affect adult retention(25).  197 
Reasons for missing clinical appointments may vary between settings. In our study, the main 198 
reported reason for LTFU was forgotten appointment (50%). Thus, mobile phone-based 199 
appointment-reminders for  caregivers could potentially decrease LTFU, as demonstrated in 200 
other studies(10). In any case, our study shows the need to improve phone detail accuracy for 201 
mobile-phone interventions. Another reason frequently reported for LTFU was change of 202 
residence (23%). This is in line with other studies showing that HIV-positive individuals with a 203 
history of mobility are less likely to be retained at successive stages of the HIV treatment 204 
cascade (26). Ultimately, it should be noted that 8% of the patients located in our study had 205 
died. Other studies found even higher mortality (2,16) which highlights the importance of 206 
implementing strategies to reduce LTFU rates and trace patients who abandon care. Further 207 
studies are needed to understand the issues that arise from calling the caregiver of a child 208 
who has died. 209 
This study has several limitations. The program located a low percentage of patients LTFU 210 
reached by the ATP. However, no significant differences were found between the baseline 211 
characteristics of patients who could be reached and those who could not, reducing the risk 212 
of selection bias. In addition, although our study was small, we clearly identified important 213 
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risk factors for RIC. A larger sample size of children with similar characteristics could increase 214 
the power and thus validity and generalizability of results.  215 
In conclusion, active telephone tracing is a potential strategy to facilitate re-engagement in 216 
HIV care; however, every effort should be made to record correct numbers, including 217 
alternative/multiple numbers to maximize the patients reached.  218 
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